title: Cooperative disease management programs.
abstract: Cooperative disease management programs sponsored by pharmaceutical companies and managed care organizations or health care providers can offer significant benefits to patients. They can be structured so as to comply with applicable OIG, FDA, and IRS regulations. Such programs must be structured for the benefit of patients, and not to require the use of or otherwise directly promote the selection of the sponsoring pharmaceutical company's products.
authors.affiliation: McDermott, Will & Emery, Boston, Massachusetts, USA.
authors.forename: C M
authors.initials: CM
authors.lastname: Jedrey
authors.forename: K A
authors.initials: KA
authors.lastname: Chaurette
authors.forename: L B
authors.initials: LB
authors.lastname: Winn
mesh_terms: D003299:Cooperative Behavior; D019468:Disease Management; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D005607:Fraud / Q000331:legislation & jurisprudence*; D006801:Humans; D007373:Interinstitutional Relations; D008329:Managed Care Programs / Q000191:economics / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D017146:Models, Organizational; D018584:Physician Self-Referral / Q000331:legislation & jurisprudence; D011785:Quality Assurance, Health Care; D011788:Quality of Life; D019464:Tax Exemption; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration